North America Saliva Test Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

North America Saliva Test Devices Market Segmentation, By Product Type (Portable Devices and Table Top Devices), Type (5-Panel Saliva Test Kits, 6-Panel Saliva Test Kits, 10-Panel Saliva Test Kits, 12-Panel Saliva Test Kits, and Others), Form (Strips, Swabs and Cassettes), Detection (Drugs, Antibodies, Virus and Bacteria, Hormones, Antigens, and Others), Application (Criminal Justice Testing, Workplace Testing and Disease Testing), End User (Hospitals, Investigation Laboratories, Diagnostic Centers and Others), Distribution Channel (Direct Tenders, Retails Sales and Third Party Distribution) - Industry Trends and Forecast to 2032

North America Saliva Test Devices Market Size

• The North America saliva test devices market size was valued at USD 1.57 billion in 2024 and is expected to reach USD 2.58 billion by 2032, at a CAGR of 6.4% during the forecast period
• The market growth is largely fueled by the increasing demand for non-invasive diagnostic methods, technological innovations in point-of-care testing, and the growing prevalence of chronic and infectious diseases in the region
• Furthermore, rising awareness of early disease detection and the need for rapid, easy-to-administer, and cost-effective testing solutions is driving adoption across clinical, workplace, and home-based settings. These converging factors are accelerating the uptake of saliva test devices, thereby significantly boosting the industry's growth

North America Saliva Test Devices Market Analysis

• Saliva test devices, providing non-invasive, rapid diagnostic solutions, are becoming essential tools in healthcare, workplace testing, and at-home health monitoring across North America due to their ease of use, cost-effectiveness, and ability to detect a wide range of conditions from infectious diseases to hormonal imbalances
• The growing demand for saliva-based diagnostics is primarily driven by increasing awareness of early disease detection, advancements in molecular diagnostic technologies, and a shift toward decentralized and remote healthcare solutions
• U.S. dominated the North America saliva test devices market with the largest revenue share of 79% in 2024, fueled by high healthcare spending, strong regulatory support for innovative diagnostics, and growing adoption of home-based testing kits, particularly during and post-COVID-19, with leading companies investing in portable, AI-enabled, and smartphone-integrated solutions
• Canada is expected to be the fastest growing country in the North America saliva test devices market during the forecast period, owing to increased public health initiatives and growing demand for accessible diagnostic tools in rural and underserved communities
• Portable devices segment dominated the North America saliva test devices market with a market share of 70.5% in 2024, driven by its ease of use, mobility, and suitability for point-of-care and remote testing environments

Report Scope and North America Saliva Test Devices Market Segmentation 

North America Saliva Test Devices Market Trends

“Growing Shift Toward Non-Invasive, At-Home, and Rapid Diagnostics”

• A major and accelerating trend in the North America saliva test devices market is the increasing consumer and clinical preference for non-invasive, easy-to-administer testing solutions that can be used in decentralized or at-home settings. This shift is driven by the demand for rapid diagnostics that minimize discomfort and offer quicker turnaround times

  • For instance, Cue Health’s molecular saliva test kits have gained traction in the U.S. for their ability to deliver lab-quality results at home through app-connected devices. Similarly, Salimetrics has expanded its portfolio with hormone and virus testing solutions tailored for remote and research-based applications

• Integration with mobile health apps and wearable ecosystems is another emerging trend, allowing users to track results, receive alerts, and share data with healthcare providers in real time. Some test kits now feature Bluetooth connectivity and app-based interpretation, enabling personalized and connected diagnostics
• The growing importance of saliva as a diagnostic fluid—capable of detecting stress markers, hormones, antibodies, and viral RNA—has led to a surge in R&D investments focused on expanding the capabilities of saliva-based test kits for diverse medical applications beyond COVID-19, such as fertility monitoring, drug screening, and chronic disease management
• This trend is reshaping consumer expectations for testing, with an emphasis on ease, speed, and integration with digital healthcare platforms. As a result, companies are increasingly launching portable, AI-enhanced saliva devices that offer multiplex testing and compatibility with telehealth platforms, especially across the U.S. and Canada

North America Saliva Test Devices Market Dynamics

 Driver

            “Increased Adoption of Rapid and Non-Invasive Testing Solutions”

• The growing preference for painless and user-friendly testing procedures, coupled with heightened awareness of disease prevention, is driving the adoption of saliva-based diagnostics in North America

  • For instance, the COVID-19 pandemic accelerated public acceptance of saliva as a reliable diagnostic medium, prompting companies such as OraSure Technologies and Thermo Fisher Scientific to develop and distribute a broader range of saliva-based tests

• These devices provide quick results without the need for trained professionals, making them ideal for schools, workplaces, airports, and home testing scenarios. In addition, regulatory bodies such as the FDA have supported market growth by granting Emergency Use Authorization (EUA) and fast-tracking approvals for novel saliva-based kits
• The trend toward decentralization of healthcare, where consumers demand greater control over health data and diagnostic access, continues to fuel the integration of saliva testing devices into wellness apps, remote care services, and preventive health programs

Restraint/Challenge

             “Regulatory Barriers and Concerns Over Accuracy and Sample Stability”

• Despite the growing acceptance of saliva testing, the market faces challenges related to regulatory compliance, variability in sample stability, and diagnostic accuracy, especially for complex conditions or in early-stage detection
• Inconsistent sensitivity and specificity across different saliva test formats have raised concerns among clinicians about reliability compared to traditional blood-based or nasopharyngeal samples
• Moreover, navigating the complex FDA regulatory environment for diagnostic devices in the U.S. requires companies to invest heavily in validation studies, compliance protocols, and documentation, which may slow product rollouts and increase time-to-market
• Cold chain requirements and sample degradation in certain test types also limit widespread usage, especially in rural or under-resourced settings. Addressing these challenges through innovation in sample preservation, quality control, and regulatory streamlining will be crucial to sustaining growth and consumer confidence

North America Saliva Test Devices Market Scope

The market is segmented on the basis of product type, type (test panel), form, detection, application, end user, and distribution channel.

• By Product Type

On the basis of product type, the North America saliva test devices market is segmented into portable devices and table top devices. The portable devices segment dominated the market with the largest market revenue share of 70.5% in 2024, driven by its ease of use, suitability for point-of-care and home-based testing, and growing demand for decentralized diagnostics. These devices are preferred in workplaces, educational institutions, and field settings due to their mobility, affordability, and rapid result delivery.

The table top devices segment, while smaller in market share expected to witness fastest growth during forecast period, remains vital in centralized healthcare settings such as hospitals and diagnostic labs that require more detailed, lab-grade analyses.

• By Type

On the basis of type, the North America saliva test devices market is segmented into 5-panel saliva test kits, 6-panel saliva test kits, 10-panel saliva test kits, 12-panel saliva test kits, and others. The 5-panel test kits segment dominated the market with the largest market revenue share of 56.3% in 2024, supported by widespread use in workplace and legal drug screening programs. These kits test for the most commonly abused substances and are cost-effective, simple to administer, and widely available.

The 6-panel saliva test kits segment is anticipated to witness notable growth during the forecast period, driven by growing demand for expanded substance detection and compliance with more stringent drug testing protocols.

• By Form

On the basis of form, the North America saliva test devices market is segmented into strips, swabs, and cassettes. The strips segment led the market with the highest market revenue share in 2024, driven by its affordability, convenience, and ability to provide quick visual results. These are commonly used in both at-home and field testing scenarios.

The swabs and cassettes segments are also growing steadily during forecast period, particularly in professional diagnostic and clinical settings that require enhanced sample stability and multi-analyte testing formats.

• By Detection

On the basis of detection, the North America saliva test devices market is segmented into drugs, antibodies, virus and bacteria, hormones, antigens, and others. The drug detection segment dominated the market with the largest market revenue share in 2024, owing to the high demand for drug screening in employment, law enforcement, and legal proceedings. Saliva testing offers a less invasive, fast, and cost-effective alternative to urine or blood tests.

The virus and bacteria detection segment is expected to witness accelerated growth during forecast period, supported by increased investment in infectious disease diagnostics post-COVID-19 and rising interest in scalable, rapid, non-invasive testing solutions.

• By Application

On the basis of application, the North America saliva test devices market is segmented into criminal justice testing, workplace testing, and disease testing. The workplace testing segment dominated the market with the largest market revenue share of 48.6% in 2024, driven by corporate drug policies, occupational safety regulations, and increased awareness of substance use in professional environments.

The criminal justice testing segment is expected to witness fastest growth during forecast period, due to its role in parole, probation, and roadside testing, while disease testing is emerging as a promising area, especially for hormone, viral, and chronic disease diagnostics.

• By End User

On the basis of end user, the North America saliva test devices market is segmented into hospitals, investigation laboratories, diagnostic centers, and others. The hospitals segment dominated the market with the largest market revenue share in 2024, supported by increased diagnostic throughput, growing patient volumes, and early technology adoption.

The investigation laboratories and diagnostic centers segments are also expected to grow at faster CAGR rate during forecast period, particularly in forensic science, research institutions, and specialized screening services.

• By Distribution Channel

On the basis of distribution channel, the North America saliva test devices market is segmented into direct tenders, retail sales, and third-party distribution. The direct tenders segment dominated the market with the largest market revenue share of over 50% in 2024, driven by institutional purchases from hospitals, government agencies, and corporate programs requiring bulk and contract-based supply of test kits.

The retail sales and third-party distribution channels are expanding rapidly during forecast period, due to increasing demand for over-the-counter products, e-commerce availability, and self-testing kits for home use

North America Saliva Test Devices Market Regional Analysis

• The U.S. dominated the North America saliva test devices market with the largest revenue share of 79% in 2024, fueled by high healthcare spending, strong regulatory support for innovative diagnostics, and growing adoption of home-based testing kits, particularly during and post-COVID-19, with leading companies investing in portable, AI-enabled, and smartphone-integrated solutions
• Consumers in the U.S. highly value the ease of sample collection, fast result turnaround, and the ability of saliva-based tests to detect a wide range of conditions without the need for clinical visits
• This market dominance is further supported by advanced healthcare infrastructure, regulatory approvals, and the presence of leading diagnostic companies offering portable, digital, and app-connected testing solutions tailored for both home and institutional use

U.S. North America Saliva Test Devices Market Insight

The U.S. saliva test devices market captured the largest revenue share of 79% in 2024 within North America, fueled by a strong demand for non-invasive, rapid diagnostic tools across healthcare, workplace, and at-home settings. Consumers and institutions increasingly favor saliva-based tests for their ease of use, cost-effectiveness, and suitability for frequent screening. The market is further propelled by the growing popularity of telehealth, regulatory support for self-testing kits, and the widespread use of saliva diagnostics in drug screening, infectious disease detection, and hormone monitoring. Moreover, ongoing technological advancements—such as smartphone integration and AI-enhanced result interpretation—are accelerating adoption across both consumer and clinical domains.

Canada Saliva Test Devices Market Insight

The Canada saliva test devices market is projected to expand at a steady CAGR throughout the forecast period, driven by national healthcare initiatives promoting early disease detection and the increasing use of non-invasive testing methods in public health and research settings. Saliva testing is gaining traction in schools, workplaces, and remote communities due to its minimal training requirements and rapid turnaround times. With growing investment in digital health infrastructure and the presence of academic research institutions, Canada is strengthening its role in the regional market, particularly in the development and application of advanced diagnostic technologies.

Mexico Saliva Test Devices Market Insight

The Mexico saliva test devices market is anticipated to grow at a notable CAGR during the forecast period, supported by expanding healthcare access, rising public awareness of preventive diagnostics, and growing government focus on substance abuse monitoring and disease surveillance. Increased urbanization and demand for affordable, accessible testing solutions are encouraging adoption across both public and private sectors. Additionally, the market benefits from increasing partnerships with international diagnostic companies, which are introducing cost-effective, portable saliva test kits suitable for broader deployment across Mexico’s healthcare landscape.

North America Saliva Test Devices Market Share

The North America saliva test devices industry is primarily led by well-established companies, including:

• OraSure Technologies, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Salimetrics, LLC (U.S.)
• Abbott (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Labcorp (U.S.)
• Everlywell, Inc. (U.S.)
• Spectrum Solutions, LLC (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• NEOGEN Corporation (U.S.)
• Premier Biotech, Inc. (U.S.)
• DNAlite Therapeutics, Inc. (U.S.)
• ZRT Laboratory, LLC (U.S.)
• Biocompare, Inc. (U.S.)
• Avioq, Inc. (U.S.)
• Precision Analytical Inc. (U.S.)
• Vault Health, Inc. (U.S.)
• Viome Life Sciences, Inc. (U.S.)
• Mirimus, Inc. (U.S.)
• DNA Genotek Inc. (Canada)

What are the Recent Developments in North America Saliva Test Devices Market?

• In April 2024, OraSure Technologies, Inc., a U.S.-based leader in point-of-care diagnostic testing, announced the launch of an upgraded saliva-based COVID-19 and influenza combo test for home and clinical use. This next-generation product provides faster results and improved accuracy, aligning with increasing consumer demand for multi-pathogen, self-administered diagnostics. The development reflects OraSure’s commitment to enhancing public access to non-invasive testing solutions that support early detection and disease management
• In March 2024, Salimetrics, LLC, a Pennsylvania-based biotechnology company, expanded its clinical research applications by introducing saliva-based hormone and immune function test kits to academic and wellness institutions across North America. These kits are designed for non-invasive biomarker collection and analysis, supporting studies in stress, fertility, and chronic disease management. The initiative reinforces Salimetrics' position as a trusted provider of high-quality saliva testing solutions in both clinical and research domains
• In February 2024, Thermo Fisher Scientific Inc. partnered with U.S. public health departments to pilot saliva-based drug testing programs targeting substance abuse in community health centers and schools. This collaboration aims to provide rapid, low-cost, and minimally invasive testing to underserved populations, advancing the company’s role in supporting public health initiatives and enhancing early intervention efforts in addiction treatment
• In January 2024, Spectrum Solutions, LLC, a U.S. provider of molecular diagnostic collection devices, announced FDA emergency use authorization (EUA) for its saliva-based pathogen detection device that enables simultaneous screening of multiple viruses. This development signifies a leap forward in multiplex testing, offering clinical laboratories and at-home users a streamlined solution for broader infectious disease surveillance
• In January 2024, Everlywell, Inc., a prominent at-home diagnostics company, launched a saliva-based hormone testing kit focused on women's health, with digital result integration and telehealth support. This innovation highlights the growing trend toward personalized health monitoring and remote diagnostics, catering to consumer preferences for privacy, accessibility, and convenience in managing hormonal health and wellness

SKU-61627